The Hazard Ratio ( HR ) for OS comparing SLNB-alone with ALND adjusting for age , adjuvant radiotherapy , tumor size , estrogen receptor status , grade and tumor type resulted in an HR of 1.05 ( 95 % CI , 0.72-1 .54 , p = 0.77 ) .